✦ LIBER ✦

Effects of rifampicin on the pharmacokinetics of roflumilast and roflumilast N-oxide in healthy subjects

✍ Scribed by Nassr Nassr; Andreas Huennemeyer; Rolf Herzog; Oliver Von Richter; Robert Hermann; Manuela Koch; Kevin Duffy; Karl Zech; Gezim Lahu

Book ID: 108642362
Publisher: John Wiley and Sons
Year: 2009
Tongue: English
Weight: 657 KB
Volume: 68
Category: Article
ISSN: 0306-5251
DOI: 10.1111/j.1365-2125.2009.03478.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of Steady-State Enoxacin on Singl

Effect of Steady-State Enoxacin on Single-Dose Pharmacokinetics of Roflumilast and Roflumilast N-Oxide

✍ Lahu, Gezim; Nassr, Nassr; Herzog, Rolf; Elmlinger, Martin; Ruth, Peter; Hinder, 📂 Article 📅 2011 🏛 Sage Publications 🌐 English ⚖ 228 KB

Pharmacokinetics and safety of Roflumila

Pharmacokinetics and safety of Roflumilast, a once-daily, oral, selective PDE4 inhibitor, and its active metabolite Roflumilast N-oxide in healthy subjects*1

✍ HUENNEMEYER, A 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 26 KB

Effect of Fluvoxamine on the Pharmacokin

Effect of Fluvoxamine on the Pharmacokinetics of Roflumilast and RoflumilastN-Oxide

✍ Oliver von Richter, Gezim Lahu, Andreas Huennemeyer, Rolf Herzog, Karl Zech, Rob 📂 Article 📅 2007 🏛 Springer International Publishing AG 🌐 English ⚖ 153 KB

The glucose-lowering effects of the PDE4

The glucose-lowering effects of the PDE4 inhibitors roflumilast and roflumilast-N-oxide indb/dbmice

✍ Vollert, S.; Kaessner, N.; Heuser, A.; Hanauer, G.; Dieckmann, A.; Knaack, D.; K 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 418 KB

Lack of a pharmacokinetic interaction be

Lack of a pharmacokinetic interaction between steady-state roflumilast and single-dose midazolam in healthy subjects

✍ Nassr Nassr; Gezim Lahu; Oliver Von Richter; Felix Reutter; Dietrich Knoerzer; K 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 149 KB

Investigation of a Potential Food Effect

Investigation of a Potential Food Effect on the Pharmacokinetics of Roflumilast, an Oral, Once-Daily Phosphodiesterase 4 Inhibitor, in Healthy Subjects

✍ Hauns, Bernhard; Hermann, Robert; Hünnemeyer, Andreas; Herzog, Rolf; Hauschke, D 📂 Article 📅 2006 🏛 Sage Publications 🌐 English ⚖ 97 KB